CLOV vs HSIC · rev $1.37B vs P/E 24, rev $12.67B
Clover Health Investments Corp (CLOV) versus Henry Schein Inc (HSIC) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Henry Schein Inc (HSIC) is a medical distribution company listed on NASDAQ.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported HSIC revenue for 2024-12-28 was $12.67B. Net income was $398.0M. Revenue was up 2.7% from 2023-12-30 to 2024-12-28. HSIC currently screens at market cap $9.11B and trailing P/E 24.2.
CLOV currently screens at market cap $1.55B. HSIC currently screens at market cap $9.11B and trailing P/E 24.2.
Not investment advice. Open the CLOV and HSIC stock pages for the full models.
Not investment advice.